Clinical Characteristics | Groups | P value | |
---|---|---|---|
non-131I-avid (N = 47) | 131I-avid (N = 72) | ||
Age/years | 0.55 | ||
Median (range) | 43 (28–60) | 42 (27–55) | |
Gender | 0.90 | ||
Male (%) | 21 (44.7) | 33 (45.8) | |
Female (%) | 26 (55.3) | 39 (54.2) | |
Tg level (ng/ml) | 0.77 | ||
Median (range) | 1213.5 (304.7–3121.9) | 1324.3 (324.9–3249.5) | |
TgAb level (IU/ml) | 0.72 | ||
Median (range) | 45.6 (10–125.6) | 43.8 (10–150.3) | |
Histological diagnosis | PTC | PTC | – |
Primary tumor | – | ||
T stage | – | ||
T1 | 17 | 27 | – |
T2 | 19 | 30 | – |
T3 | 9 | 12 | – |
T4 | 2 | 3 | – |
N stage | – | ||
N0 | 0 | 0 | – |
N1 | 46 | 70 | – |
Nx | 1 | 2 | – |
Chest CT scan | Diffuse small nodules | Diffuse small nodules | – |
131I up take in lungs | Close to upper limbs | Diffuse lung uptake | – |
Extent of disease | No other metastasis | No other metastasis | – |
Other cancer history | No | No | – |
Other treatment | No | No | – |